Current policies on early detection of prostate cancer create overdiagnosis and inequity with minimal benefit

Affiliations

• ¹ Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, USA vickersa@mskcc.org.
• ² Department of Urology, Cork University Hospital, Ireland.
• ³ University Vita-Salute San Raffaele, Italy.
• ⁴ Department of Surgery, University College Dublin, Ireland.
• ⁵ Department of Urology, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Sweden.
• ⁶ Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, USA.
• ⁷ Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, USA.
• ⁸ Academic Urology Unit, Department of Oncology and Metabolism, University of Sheffield, UK.
• ⁹ Division of Personalized Early Detection of Prostate Cancer, German Cancer Research Center (DKFZ), Heidelberg, Germany.
• ¹⁰ Patient and patient advocate, New York, USA.
• ¹¹ Department of Urology, University Hospital, Medical Faculty, Heinrich-Heine-University Düsseldorf, Germany.